マウス脳から扁桃体領域を露出させる冠状脳スライスの生成

Executive Industry Relevance

This method enables the preparation of viable brain slices that preserve synaptic connections between the amygdala and medial prefrontal cortex, supporting mechanistic studies of fear and anxiety circuits. By maintaining neuronal integrity, it provides a reliable platform for target validation and assay development in neuropsychiatric drug discovery. The approach facilitates early-stage mechanistic de-risking by allowing direct interrogation of neural pathway function in a disease-relevant system.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of amygdala-mPFC synaptic connections to validate targets involved in fear and anxiety regulation.
• Operational Value: Provides a reproducible preparation method for studying neural circuit function in a controlled ex vivo setting.

Screening & Assay Development

• Scientific Value: Generates brain slices with preserved neuronal viability suitable for electrophysiological or imaging-based assays.
• Operational Value: Supports standardization of slice preparation for consistent compound screening outcomes.

Translational & Preclinical Research

• Scientific Value: Offers a disease-relevant system to assess target engagement in circuits implicated in emotional processing disorders.
• Operational Value: Enables continuity from discovery to preclinical evaluation by maintaining physiological neural properties.

Pipeline & Workflow Integration

The method fits within the early discovery continuum, supporting hypothesis testing and pathway clarification before advancing to lead identification stages.

• Discovery Biology: Facilitates hypothesis testing of amygdala-mPFC interactions in fear and anxiety pathways.
• Screening: Enables assay-ready preparations with consistent neuronal health for compound evaluation.
• Analytics: Provides a platform for quantitative measurements of synaptic activity and neuronal responses.
• Translational Research: Supports continuity to preclinical work by preserving native circuit function.
• Enterprise Reuse: Establishes a standardized slicing protocol applicable across multiple neuroscience projects.

Operational & Enterprise Impact

• Scientific Value: Enhances predictive confidence by preserving native synaptic connections in a physiologically relevant preparation.
• Operational Value: Ensures reproducibility and scalability of brain slice production for multi-well or high-content applications.
• Strategic Value: Reduces biological uncertainty in target selection by enabling direct functional validation of neural circuits.
• Portfolio Impact: Informs risk-adjusted prioritization of compounds targeting fear and anxiety pathways through mechanistic de-risking.

Implementation Considerations

• Requires expertise in neuroanatomy and vibratory sectioning techniques.
• Dependent on precision instrumentation such as a vibratome and interface chamber.
• Necessitates standardized protocols for artificial cerebrospinal fluid composition and temperature control.
• Involves adaptation considerations when applying to different mouse strains or developmental stages.
• Limited by tissue viability duration post-slicing, requiring timely experimental execution.

Biopharma FAQs